Hotline: 400-6858-510

Announcements:

The warm congratulations website officially opened!

Home > News > Industry News

News

Industry News

The plant extracts Property next year ushered in International Business Standard

Font Size: [Big][Mid][Small] 2013-1-11  Views: 2143

The standard has been the soft underbelly of the plant extract industry in China. Recently confirmed from the Chinese medicine (600,056, stock it) and Health Products Import and Export Chamber of Commerce, the first plant extracts international business standards fastest will be announced in March 2013, will be the new face of the future of plant extract industry show in the international arena.
It is reported that the forthcoming 11 plant extracts standard products are: bilberry extract, green tea extract, ginkgo biloba extract, grape seed extract, milk thistle extract, Polygonum cuspidatum extract, Centella asiatica extract switchgrass extract, ginseng extract, hesperidin and rutin extract.
Chinese Medicines and Health Products Import and Export Chamber of Commerce vice president Liu Zhang told reporters that the plant extracts formulated by international business standard indicators and measurement methods will be combined reference to international standards or pharmacopoeia requirements for products exported to the European Union, the United States, Japan and other international market, more varieties standards are coming formulate.
The standard of the storm
The data show that, in 2017, the global botanical supplements and herbal sales will reach $ 107 billion. Increasing global demand for plant types of APIs In recent years, China's the plant extracts exports more all the way up. But beautiful figures do not cover up the defects of the plant extract industry in China.
Forum held in October 2012 China plant extracts industry to enhance the international competitiveness of the State General Administration of Quality Supervision, Inspection and Quarantine Import and Export Food Safety Bureau Director Han Yi laments: "The state is currently no unified policy and related laws and regulations are not sound, state of plant extract material industry positioning is not clear so many plant extract products have not a uniform quality standards, these soft environment constraints of our plant extract industry's development. "has been China's extract industry on the international market dependent degrees very high, 80% of the products are exported to foreign countries;, as the global botanical supplements and herbal largest consumer regions, Europe and North America, 70% of vegetable raw materials from China. As the market increases, Europe and the United States increasingly stringent regulations on herbal supplements and medicines.
Reference to international standards using advanced testing, testing techniques and methods, and more plant extract items kinds of the perfect standard industry standard system, and is common in the industry to be established as soon as possible with the International Institute for the Unification of standards to meet international market demand, voice. Xi'an Haotian Bio-Engineering Co., Ltd., general manager, plant extracts Association said: "After the international financial crisis, the three major markets of Europe, the United States and Japan showed a strong trend of localization, the implant Zhang CW The price, cost and safety of the products proposed new requirements. "
Example, extract sik as our main export market, the United States and Europe, the two together accounted for about 58% of our total plant extract export from 2006 start the implementation of more stringent new dietary supplement cGMP regulations. Due sik extract quality standards (including pesticide residues, heavy metals and microbial colonies quantity indicators) performed in Europe and the United States as well as Japan and other developed countries are very strict, resulting in domestic enterprises to plant under no small pressure.
The biggest shock of the plant extract industry in early 2012, the non-General Administration of Customs and the State General Administration of Quality Supervision, Inspection and Quarantine of the adjustment of the law review directory "is none other than the shockwave from the current lack of product standards of the majority of plant extracts. In this regard, Guangdong pharmaceutical companies pharmaceutical senior engineer Mr. Xia told reporters expressed frustration: "Since no criteria to guide plant extracts export enterprises in China has been to follow the customer standards, can only passively production according to customer requirements."
This status quo, Liu Zhang also expressed great concern: "in accordance with the other requirements, the operation is simple, but the drawbacks are obvious. Once the customer to challenge the quality of products, production enterprises will be controlled by others, have suffered losses," disadvantage "enterprise countless. "At the same time, the plant extracts exports in China in order to break through the technical barriers in developed countries, the plant extracts export standards must be devised and strictly enforced. And promote the healthy development of
Popular thanks to the concept of natural health, in the situation of the poor global economic environment, despite the slowdown in export growth, but the export prospects of the future plant extracts is still optimistic. Currently, our production plant extracts kinds of goods has reached hundreds of which have been the formation of large-scale production and export plant extract of Ginkgo biloba extract, green tea extract, ginseng extract, these products are in the Western countries occupy than large market share.
Liu Zhang said: "only 11 varieties of international business standards is clearly not enough, because of the lack of standards, the implant enterprises in China is very passive in exports, time urgent and formulate procedures are very complicated, must be the bulk of emergency, several high demand The varieties do first. "
In fact, although the standard-setting process is slow, but the industry is generally convinced that our plant extract industry in the field of traditional Chinese medicine are most likely to achieve the internationalization of the sub-sectors, but also realize the internationalization of Chinese medicine a more realistic option. Implant enterprises face the dual pressures of the international and domestic market, and improve the overall level of the industry through product registration, uniform standards, and strengthen international certification and basic research, improve innovation capabilities. "Zhang CW case said.
It is reported that currently has a small number of enterprises to carry out product certification. For example, a joint venture with Germany's Liaoning boulder Pharmaceutical, wolfberry organic planting base is the first by a U.S. NOP and European EEC2092/91 certification, the products have been sold to Europe and the United States. But the American the USP certification (including certification of dietary supplements, dietary supplement ingredients certified pharmaceutical ingredients certification) and the EU COS Certification (bulk drugs) threshold is relatively high, only a few domestic enterprises through.
Also worth mentioning is that the plant extract products play an increasingly important role in the health industry chain. Plant extracts industry as Chairman is an "aggregate" of pharmaceuticals, fine chemicals, agricultural, mainly used in the function factor, dietary supplements, functional foods industry. Expected to 2015, the functional factors, dietary supplements, functional foods industry global market of up to $ 250 billion, the Chinese market reached 500 billion yuan. Face of attractive prospects, domestic enterprises in addition to do your homework in product quality, but also from the "price war" in some epiphany and began to dig deep market segments. Xi'an Haotian For the Japanese market, product main coenzyme Q10, inositol, anthocyanins such; Chenguang Biotech (300,138, stock it) to the natural pigment products, the flagship product for capsanthin, lutein ; Ningbo Green Health by natural extracts and active ingredients of traditional Chinese medicine production-based products include cranberry, black currant, Ginkgo biloba extract; Green gold in Beijing, but extract enterprises in the Beijing area, the main products include licorice extract , bilberry extract, ginkgo flavonoids, green tea extract. In addition, in recent years, the development of faster enterprise Pan Zhi Shanghai, Zhejiang Conba (600,572, stock it), Guilin Rhine, Chengdu, China, Jilin Hong long, Tianjin spikes.
The introduction of international business standards for the enterprise, is both an opportunity and a challenge the first international standards, mainly for export to the international market, the next in the development of national standards also can refer to reference. "Liu Zhang disclosed.
Introduced in March 2013, "the plant extracts international Business Standard include 11 varieties are cranberry extract, green tea extract, ginkgo biloba extract, grape seed extract, milk thistle extract, Polygonum cuspidatum matter, Centella asiatica extract, the switchgrass extract, ginseng extract, hesperidin and rutin extract

About Us

INTRODUCTION LOGO

News

Company News Industry News

Products

Products

Service

Service

Contact Us

Contact Us

HR